Aside from the lower number of Caucasian patients receiving RT within Interval 2 (68% vs. 96%, p = 0.014), there were no significant differences in patient baseline and disease characteristics, including age, ECOG status, stage, histology, and tumour PD-L1, EGFR, and ALK status (Table 1). The gene discussed is EGFR; the disease is neoplasm.